News

45 MPs call for urgent action on medication shortages
45 MPs call for urgent action on medication shortages
Kami Kountcheva | Forty-five MPs have signed a letter calling on Health Secretary Wes Streeting to review and address the cause of medication shortages and…
AI tool detects epilepsy causes that doctors miss
AI tool detects epilepsy causes that doctors miss
Kami Kountcheva | An AI-powered tool can detect 64% of brain abnormalities linked to epilepsy that radiologists miss, according to a new study.
People can ask pharmacies for ‘emergency supply’ of medication
People can ask pharmacies for ‘emergency supply’ of medication
Kami Kountcheva | People in the UK can request an emergency supply of medicines from a pharmacy, according to the British National Formulary.
New tool helps predict epilepsy after stroke
New tool helps predict epilepsy after stroke
Kami Kountcheva | An international team of researchers has created a new tool that can help predict the risk of epilepsy developing after venous stroke.
Fenfluramine available on NHS for rare form of epilepsy LGS
Fenfluramine available on NHS for rare form of epilepsy LGS
Kami Kountcheva | Epilepsy medication fenfluramine will be funded for NHS patients with Lennox-Gastaut syndrome (LGS) from today (20 February 2025).
Be part of Purple Day 2025
Be part of Purple Day 2025
Grab a free fundraising pack and find out how you can change lives!
Valentine’s Day: Epilepsy, partnerships and “the good in people”
Valentine’s Day: Epilepsy, partnerships and “the good in people”
Emily Stanley | Three couples share their good times and tough times navigating the challenges of epilepsy together.
Men taking valproate don’t need sign-off from two specialists, says MHRA
Men taking valproate don’t need sign-off from two specialists, says MHRA
Kami Kountcheva | Men currently taking sodium valproate will not need sign off from two independent specialists to continue their treatment, the Medicines and Healthcare…
Ketamine to be trialled for status epilepticus in adults and children – US
Ketamine to be trialled for status epilepticus in adults and children – US
Kami Kountcheva | Scientists in the US have received an initial $9.3 million from the National Institutes of Health for a $30 million clinical trial…
Page 1 of 59